552 related articles for article (PubMed ID: 9244219)
21. Superiority of brain natriuretic peptide as a hormonal marker of ventricular systolic and diastolic dysfunction and ventricular hypertrophy.
Yamamoto K; Burnett JC; Jougasaki M; Nishimura RA; Bailey KR; Saito Y; Nakao K; Redfield MM
Hypertension; 1996 Dec; 28(6):988-94. PubMed ID: 8952587
[TBL] [Abstract][Full Text] [Related]
22. Circulating levels of cardiac natriuretic peptides (ANP and BNP) measured by highly sensitive and specific immunoradiometric assays in normal subjects and in patients with different degrees of heart failure.
Clerico A; Iervasi G; Del Chicca MG; Emdin M; Maffei S; Nannipieri M; Sabatino L; Forini F; Manfredi C; Donato L
J Endocrinol Invest; 1998 Mar; 21(3):170-9. PubMed ID: 9591213
[TBL] [Abstract][Full Text] [Related]
23. The potential of brain natriuretic peptide as a biomarker for New York Heart Association class during the outpatient treatment of heart failure.
Lee SC; Stevens TL; Sandberg SM; Heublein DM; Nelson SM; Jougasaki M; Redfield MM; Burnett JC
J Card Fail; 2002 Jun; 8(3):149-54. PubMed ID: 12140807
[TBL] [Abstract][Full Text] [Related]
24. Relationship between plasma levels of cardiac natriuretic peptides and soluble Fas: plasma soluble Fas as a prognostic predictor in patients with congestive heart failure.
Tsutamoto T; Wada A; Maeda K; Mabuchi N; Hayashi M; Tsutsui T; Ohnishi M; Fujii M; Matsumoto T; Yamamoto T; Takayama T; Kinoshita M
J Card Fail; 2001 Dec; 7(4):322-8. PubMed ID: 11782855
[TBL] [Abstract][Full Text] [Related]
25. N-terminal pro-atrial natriuretic peptide (N-ANP) and N-terminal pro-B-type natriuretic peptide (N-BNP) in the prediction of death and heart failure in unselected patients following acute myocardial infarction.
Squire IB; O'Brien RJ; Demme B; Davies JE; Ng LL
Clin Sci (Lond); 2004 Sep; 107(3):309-16. PubMed ID: 15182235
[TBL] [Abstract][Full Text] [Related]
26. Natriuretic peptides and cyclic guanosine 3',5'-monophosphate in asymptomatic and symptomatic left ventricular dysfunction.
Friedl W; Mair J; Thomas S; Pichler M; Puschendorf B
Heart; 1996 Aug; 76(2):129-36. PubMed ID: 8795474
[TBL] [Abstract][Full Text] [Related]
27. Right heart overload contributes to cardiac natriuretic hormone elevation in patients with heart failure.
Passino C; Maria Sironi A; Favilli B; Poletti R; Prontera C; Ripoli A; Lombardi M; Emdin M
Int J Cardiol; 2005 Sep; 104(1):39-45. PubMed ID: 16137508
[TBL] [Abstract][Full Text] [Related]
28. Cardiac natriuretic peptides for diagnosis and risk stratification in heart failure: influences of left ventricular dysfunction and coronary artery disease on cardiac hormonal activation.
Selvais PL; Donckier JE; Robert A; Laloux O; van Linden F; Ahn S; Ketelslegers JM; Rousseau MF
Eur J Clin Invest; 1998 Aug; 28(8):636-42. PubMed ID: 9767358
[TBL] [Abstract][Full Text] [Related]
29. Regional cardiac expression and concentration of natriuretic peptides in patients with severe chronic heart failure.
Hystad ME; Geiran OR; Attramadal H; Spurkland A; Vege A ; Simonsen S; Hall C
Acta Physiol Scand; 2001 Apr; 171(4):395-403. PubMed ID: 11421854
[TBL] [Abstract][Full Text] [Related]
30. Limitations of compensation by endogenous atrial natriuretic peptide in heart failure.
Tsutamoto T; Kanamori T; Wada A; Miyauchi N; Murata T; Kinoshita M
Jpn Circ J; 1992 May; 56(5):489-93. PubMed ID: 1318429
[TBL] [Abstract][Full Text] [Related]
31. BNP and ANP as diagnostic and predictive markers in heart failure with left ventricular systolic dysfunction.
Falcão LM; Pinto F; Ravara L; van Zwieten PA
J Renin Angiotensin Aldosterone Syst; 2004 Sep; 5(3):121-9. PubMed ID: 15526247
[TBL] [Abstract][Full Text] [Related]
32. Natriuretic peptide responses to acute and chronic ventricular pacing in sheep.
Rademaker MT; Charles CJ; Espiner EA; Frampton CM; Nicholls MG; Richards AM
Am J Physiol; 1996 Feb; 270(2 Pt 2):H594-602. PubMed ID: 8779835
[TBL] [Abstract][Full Text] [Related]
33. Clinical correlates of elevated plasma natriuretic peptides and Big endothelin-1 in a population of ambulatory patients with heart failure. A substudy of the Italian Network on Congestive Heart Failure (IN-CHF) registry. IN-CHF Investigators.
Masson S; Gorini M; Salio M; Lucci D; Latini R; Maggioni AP
Ital Heart J; 2000 Apr; 1(4):282-8. PubMed ID: 10824729
[TBL] [Abstract][Full Text] [Related]
34. Secretion patterns of brain natriuretic peptide and atrial natriuretic peptide in patients with or without pulmonary hypertension complicating atrial septal defect.
Nagaya N; Nishikimi T; Uematsu M; Kyotani S; Satoh T; Nakanishi N; Matsuo H; Kangawa K
Am Heart J; 1998 Aug; 136(2):297-301. PubMed ID: 9704693
[TBL] [Abstract][Full Text] [Related]
35. Impact of oxidative stress on plasma adiponectin in patients with chronic heart failure.
Tanaka T; Tsutamoto T; Nishiyama K; Sakai H; Fujii M; Yamamoto T; Horie M
Circ J; 2008 Apr; 72(4):563-8. PubMed ID: 18362426
[TBL] [Abstract][Full Text] [Related]
36. [Brain natriuretic peptide].
Tsutamoto T; Horie M
Rinsho Byori; 2004 Aug; 52(8):655-68. PubMed ID: 15478621
[TBL] [Abstract][Full Text] [Related]
37. Prognostic value of Doppler transmittal flow patterns and cardiac natriuretic peptides in patients with chronic congestive heart failure admitted for episodes of acute decompensation.
Akioka K; Takeuchi K; Yanagi S; Hirota K; Sakamoto K; Yoshimura T; Toda I; Yoshikawa J
Heart Vessels; 2000; 15(2):53-60. PubMed ID: 11199504
[TBL] [Abstract][Full Text] [Related]
38. Contrasting cardiac regional responses of A-type and B-type natriuretic peptide to experimental chronic heart failure.
Hystad ME; Klinge R; Spurkland A; Attramadal H; Hall C
Scand J Clin Lab Invest; 2000 Jul; 60(4):299-309. PubMed ID: 10943600
[TBL] [Abstract][Full Text] [Related]
39. Increased brain natriuretic peptide and atrial natriuretic peptide plasma concentrations in dialysis-dependent chronic renal failure and in patients with elevated left ventricular filling pressure.
Haug C; Metzele A; Steffgen J; Kochs M; Hombach V; Grünert A
Clin Investig; 1994 Jun; 72(6):430-4. PubMed ID: 7950153
[TBL] [Abstract][Full Text] [Related]
40. Heart failure and neuroendocrine activation: diagnostic, prognostic and therapeutic perspectives.
Kjaer A; Hesse B
Clin Physiol; 2001 Nov; 21(6):661-72. PubMed ID: 11722473
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
